MedPath
NMPA Approval

Insulin Glargine Injection

国药准字S20201001

February 5, 2020

Drug Information

甘精胰岛素注射液

来得时

注射剂

3ml:300单位/预填充SoloStar

生物制品

February 5, 2020

Company Information

Applicant Company

北京市北京经济技术开发区兴盛街7号

Manufacturing Company

北京市北京经济技术开发区兴盛街7号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甘精胰岛素注射液 - NMPA 批准文号 | MedPath